Text Size
2 studies found for:    22149876 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Everolimus;   Drug: Placebo (for Everolimus)
2 Active, not recruiting
Has Results 		Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Condition: Breast Cancer
Interventions: Drug: Everolimus;   Drug: Placebo;   Drug: Exemestane
To Top

† Indicates status has not been verified in more than two years